Secondary Amyloidosis Development in a Patient with Juvenile Rheumatoid Arthritis on TNF-alpha Inhibitors Treatment
Journal of Rheumatic Diseases
;
: 280-284, 2012.
Article
in Korean
| WPRIM
| ID: wpr-160529
ABSTRACT
Secondary amyloidosis is one of the most serious complications in chronic inflammatory diseases such as rheumatoid arthritis. The extracellular deposit of aggregates of amyloid leads to target organ dysfunction. The mainstay treatment of secondary amyloidosis is the control of underlying disease activity. Many reports have reported that TNF-alpha inhibitors improve clinical outcomes. Here, we encountered a 34-year-old patient with juvenile rheumatoid arthritis who developed secondary amyloidosis despite treatment with TNF-alpha inhibitors. We present this case and include a review of the literature.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Arthritis, Juvenile
/
Arthritis, Rheumatoid
/
Tumor Necrosis Factor-alpha
/
Amyloid
/
Amyloidosis
Limits:
Adult
/
Humans
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS